The LexTalk World Global Law and Intellectual Property Summit was held in Singapore from July 18-19, 2024, which gathered over 500 professionals worldwide to explore the latest developments and cutting-edge trends in the legal and intellectual property fields. Han Kun partner Aaron Gu was invited to the summit to share experiences, exchange views, and explore future cooperation opportunities with industry leaders and legal experts from around the world.
During the conference, the results of the Lex Falcon Global Awards were officially announced, which recognize outstanding professionals who have excellent performance in their practices and have made positive contributions to the legal services industry. Aaron Gu was the sole winner of the "Leading Lawyer of the Year" in the field of life sciences and healthcare.
In addition, as a speaker at the summit's LexTalk Speech, Mr. Gu gave a keynote speech on "China's Reforms and Achievements in Overhauling Life Sciences Regulatory Landscape". Mr. Gu also introduced the significant progress and innovations China has made in the healthcare and life sciences field since 2015. In addition, he analyzed and introduced the international cooperation trends and opportunities in China's biomedical industry and offered his experience and insights for attendees.
Mr. Gu focuses on corporate, regulatory compliance and transactional services for the life sciences, biopharmaceutical, medical, and healthcare industries, including biosecurity and human genetic resource issues, clinical trial matters, product marketing authorizations, GxP compliance, drug licensing and collaboration (license-in/out), as well as regulatory issues involved in venture capital and private equity investments, mergers and acquisitions, and foreign and outbound investments in the life sciences industries. Mr. Gu also provides advocacy advice for draft laws and regulations released by the NMPA and other Chinese governmental authorities. Specifically, Mr. Gu's practice covers a full range of products including drugs (biologics and chemical drugs), medical devices, IVDs, cosmetics, general foods, special foods (health foods, foods for special medical purposes, and infant formulas), animal drugs, animal foods, etc. Mr. Gu has been interviewed multiple times by media such as 36Kr, Caixin, Yicai, E Drug Manager, Discover Magazine, International Pharmaceutical News, Het Financieele Dagblad (The Financial Daily, The Netherlands' major medium), Jiemian, the Economic Observer, Shenlan Outlook, and Thomson Reuters (in alphabetical order).
Han Kun is widely recognized and well-known for its practice in life sciences and healthcare. In relevant practice areas, we have been continuously ranked as a first-tier law firm by authoritative legal ranking agencies, including Chambers and Partners, The Legal 500, China Business Law Journal, Asialaw Profiles, etc. Han Kun has served a broad range of both domestic and foreign clients and developed a deep understanding of industry regulatory requirements and commercial course of dealings, covering multiple practice areas such as outbound business development transactions, intellectual property, private equity and venture capital, merger and acquisition, domestic and overseas capital markets, compliance and regulatory, and dispute resolution. Our associates on the team are graduates from top law schools both in China and abroad, all fluent in Chinese and English and equipped with excellent legal writing skills.
Han Kun is well aware of the importance of professional legal services for life sciences and healthcare companies, especially those facing complex legal issues and therefore requiring special legal support. Clients value our teamwork as we fully leverage the expertise and experience of our professionals, all experts in their respective fields. Our goal is always to provide clients with thorough and practical solutions and high-quality legal services.
